Sharp Therapeutics Corp.
SHRXF
$1.29
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 824.57% | 824.57% | -- | 129.54% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -29.71% | -29.71% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 726.83% | 726.83% | -- | -- | |
|
|
|||||
| Total Current Assets | 726.83% | 726.83% | -- | -- | |
| Net Property, Plant & Equipment | -7.77% | -7.77% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 0.00% | 0.00% | -- | -- | |
| Total Assets | 194.47% | 194.47% | -- | -- | |
|
|
|||||
| Total Accounts Payable | 47.18% | 47.18% | -- | -- | |
| Total Accrued Expenses | 10.66% | 10.66% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -99.50% | -99.50% | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | -91.06% | -91.06% | -- | -- | |
|
|
|||||
| Total Current Liabilities | -91.06% | -91.06% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -2.74% | -2.74% | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -84.89% | -84.89% | -- | -- | |
|
|
|||||
| Common Stock & APIC | 336.87% | 336.87% | -- | -- | |
| Retained Earnings | -19.61% | -19.61% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 122.51% | 122.51% | -- | -44.44% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 122.51% | 122.51% | -- | -44.44% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 122.51% | 122.51% | -- | -44.44% | |
|
|
|||||